A Prospective Pilot Study Investigating the Impact of ThermaCare on Flexibility, Muscle Relaxation & Low Back Pain
A Prospective Open Label Pilot Study Investigating the Impact of ThermaCare on Flexibility, Muscle Relaxation & Low Back Pain in Two Different Populations
1 other identifier
interventional
40
1 country
3
Brief Summary
The objective of this Investigator Initiated study is to evaluate the effectiveness of ThermaCare HeatWraps in improving flexibility and low back muscle relaxation, and in participants experiencing pain, reducing pain during movement. This study is an intervention trial on two discrete subject samples; (1) people with recent back pain, and (2) people who regularly play sport. ViMove wearable sensors provide precise objective measurements of low back muscle activity and movement in real time and can capture a patient's reporting of pain during movement. Outcomes will be assessed through standard ViMove protocols in conjunction with multiple validated measures of pain, perception of change, and function.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable low-back-pain
Started Jul 2017
Shorter than P25 for not_applicable low-back-pain
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 9, 2017
CompletedFirst Posted
Study publicly available on registry
May 12, 2017
CompletedStudy Start
First participant enrolled
July 3, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 21, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 21, 2017
CompletedResults Posted
Study results publicly available
May 10, 2019
CompletedMay 10, 2019
April 1, 2019
6 months
May 9, 2017
February 6, 2019
April 17, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Movement Data Over Time
Collection of movement data from all participants. The results listed here depict the average change in Trunk Range of Motion (ROM) between day 1 and day 2 PM sessions
Change from Baseline movement data after 1 consecutive day.
Change in Erector Spinae Muscle Activity Over Time
Collection of erector spinae muscle activity data from all participants. The results provided depict the mean muscle-activity difference between the day 1 and day 2 PM sessions. Surface Electromyography (sEMG) sensors are adhered utilizing a height-specific sensor placement template. Placement is parallel with the L3 vertebrae. Evaluated in the form of the flexion-relaxation response. When performing a forward flexion movement, muscle activation occurs at the commencement of the movement (when bending down;concentric), as well as during the return to the upright position (eccentric). At maximum flexion, minimal muscle activation is expected (i.e. muscle relaxation). However, in subjects with Low-back pain, muscle relaxation is often absent. As such, the following formula is used to evaluate the flexion-relaxation response. Sum of sEMG activity at maximum flexion divided by the summed sEMG activity of both concentric and eccentric muscle activation.
Change from Baseline Erector spinae muscle activity data after 1 consecutive day.
Secondary Outcomes (7)
A Change Over Time in Range of Motion in Any One Plane of Movement Compared to Pre-intervention Range of Motion.
Change from Baseline after 1 consecutive day.
In Group 1 (LBP Patients), a Change in Maximum Pain During Movement Score, for Any One Plane of Movement.
Change from Baseline after 1 consecutive day.
A Change in Muscle Activity From Baseline in Subjects Where Abnormal EMG Activity During Baseline is Detected.
Change from Baseline after 1 consecutive day.
Change in Pain From Baseline
Change from Baseline after 1 consecutive day.
Observation of Self-reported Changes in Functional Status Pre- and Post- ThermaCare Application as Measured by the Oswestry Disability Index (ODI) if Subjects Scored >3 on the NRS
Change from Baseline after 1 consecutive day.
- +2 more secondary outcomes
Study Arms (2)
Low Back Pain Group
EXPERIMENTALLow Back Pain (LBP) group will be assessed on two consecutive days. The first day will have no ThermaCare intervention applied, and is for a Baseline assessment of flexibility, muscle relaxation and low back pain. The second day will have the ThermaCare Low Back Heat Wrap intervention applied, and will have the same assessments as the Baseline day.
Active in Sport Group
EXPERIMENTALSport group will be assessed on two consecutive days. The first day will have no ThermaCare intervention applied, and is for a baseline assessment of flexibility, muscle relaxation and low back pain. The second day will have the ThermaCare Low Back Heat Wrap intervention applied, and will have the same assessments as the Baseline day.
Interventions
The ThermaCare Low Back Heat Wrap, is a continuous, low-level, direct heat therapy. It comes in the form of a heat-pack that is strapped to the low back. Heat is provided for approximately 8-hours.
Eligibility Criteria
You may qualify if:
- Adults between the age of 21-54 inclusive, male and female.
- Low back pain is the primary source of pain over the last 3 weeks.
- Have experienced and received treatment for muscle related low back pain with an average score of at least 3/10 on a 10-point Numeric Rating scale over the past 3 weeks.
- Must be able to communicate fluently in English.
- Must provide written informed consent.
- Must agree to confidentiality.
- Adults between the age of 21-54 inclusive, male and female.
- Participate in 30 min of moderate to high intensity exercise 3 times per week. As defined by Borg Rating of Perceived Exertion scale.
- Must be able to communicate fluently in English.
- Must provide written informed consent.
- Must agree to confidentiality.
You may not qualify if:
- The subject is pregnant.
- The subject has a severe hearing impairment.
- The subject is cognitively impaired.
- Known allergic skin reaction to tapes and plasters.
- Co-morbidities of neoplasm, infection, fracture, inflammatory or metabolic disorder that has potential to affect the lumbo-pelvic region.
- Person who is currently enrolled in another investigational drug or device study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- dorsaVi Ltdlead
- Monash Universitycollaborator
Study Sites (3)
Clifton Hill Physiotherapy
Clifton Hill, Victoria, 3068, Australia
Peak MSK Physiotherapy
Hampton, Victoria, 3188, Australia
Hoppers Physio
Hoppers Crossing, Victoria, 3168, Australia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Sangeeth Wanasinghage
- Organization
- dorsaVi Ltd
Study Officials
- PRINCIPAL INVESTIGATOR
Andrew Ronchi, PhD
dorsaVi Ltd
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Masking Details
- This study is open label, meaning that no masking occurs
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 9, 2017
First Posted
May 12, 2017
Study Start
July 3, 2017
Primary Completion
December 21, 2017
Study Completion
December 21, 2017
Last Updated
May 10, 2019
Results First Posted
May 10, 2019
Record last verified: 2019-04